A steady dinner with protein, fiber, and fat can help, while sugary snacks late can make the night choppy
Given the increasing emphasis on the use of GLP-1 RAs in clinical practice, it is important that all members of the healthcare team, including pharmacy professionals, understand current recommendations and patient-specific considerations for use
During the first weeks of GLP-1 therapy, many patients experience a temporary worsening of GI symptoms before they improve
A patients history may reveal a prolonged struggle with pain and associated symptoms that have been resistant to conventional analgesics or treatments targeting peripheral pain, such as injections
The research literature consistently describes DSIP as a sleep-promoting neuromodulator not a hypnotic or sedative agent with a modulating effect on sleep and wake functions that is most pronounced when sleep is disturbed, and minimal in healthy subjects without sleep disruption